<?xml version="1.0" encoding="UTF-8"?>
<p>Raters remain blind to randomised treatment condition (valacyclovir or placebo). The blind is not broken during the entire trial. In case of clinical emergency, the blinded treatment (valacyclovir or placebo) is continued if possible. Treatment interruption for up to 6 weeks is allowed, typically for intervening medical/surgical conditions.</p>
